Irafamdastat

Overview

Irafamdastat (BMS-986368) (Example 74) is a FAAH and MAGL inhibitor, with IC 50 s ≤ 100 nM (human FAAH ) and 100 nM-1 μM (human MAGL ) respectively. Irafamdastat has antiepileptic effect.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Pain | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > MAGL | Products > Signaling Pathways > FAAH

Product Information

• Catalog No.: HY-177093
• CAS No.: 2244136-58-9
• Molecular Formula: C20H21F3N4O4
• Molecular Weight: 438.40
• Purity: 98.07%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 5 mg/mL (11.41 mM); Clear solution
• Availability: In-stock

Source

Original product source